Poll Archive


	Current Papers
	ARF Recommends
	Milestone Papers
	Search All Papers
	Search Comments


	Research News
	Drug News
	Conference News


	AD Hypotheses
		AlzSWAN
		Current Hypotheses
		Hypothesis Factory
	Forums
		Live Discussions
		Virtual Conferences
		Interviews
	Enabling Technologies
		Workshops
		Research Tools
	Compendia
		AlzGene
		AlzRisk
		Antibodies
		Biomarkers
		Mutations
		Protocols
		Research Models
		Video Gallery
	Resources
		Bulletin Boards
		Conference Calendar
		Grants
		Jobs


	Overview
	Diagnosis/Genetics
	Research
	News
	Profiles
	Clinics


	Companies
	Tutorial
	Drugs in Clinical Trials


	About Alzheimer's
		FAQs
	Diagnosis
		Clinical Guidelines
		Tests
		Brain Banks
	Treatment
		Drugs and Therapies
	Caregiving
		Patient Care
		Support Directory
		AD Experiences


	Member Directory
	Researcher Profiles
	Institutes and Labs


	Mission
	ARF Team
	ARF Awards
	Advisory Board
	Sponsors
	Partnerships
	Fan Mail
	Support Us

Home: Community

SITE POLL ARCHIVE

Important Notice: Opine Online provides an informal way for the research community to express its views on current topics. The results are not a scientific poll and do not necessarily reflect the percentages of all Alzheimer researchers who agree with these positions.

August 2010

Poll Question: Should the FDA be allowed to use data from overseas clinical trials?

Absolutely, we are running out of viable subjects in the U.S.
9
Yes, so long as the data is reliable
31
No, the trials are not as rigorous
3
No, the data should be repeated in the U.S.
5
No, the drug sponsors are just trying to cut corners
3

Responses: 51

	Comments on Site Poll

	Comment by: Heriberto Acosta
	Submitted 13 September 2010 \| Permalink	Posted 27 September 2010
	Yes, we need more trials around the world View all comments by Heriberto Acosta

	Comment by: Wai-Tong Chien
	Submitted 9 February 2011 \| Permalink	Posted 9 February 2011
	Yes, it is much better to have data from different study settings, across populations and cultures, so long as the data are reliable. Then, the findings can be generalized to worldwide study populations. View all comments by Wai-Tong Chien

	Comment by: Kimberly Jones
	Submitted 7 November 2011 \| Permalink	Posted 7 November 2011
	Yes, so long as the data are reliable. View all comments by Kimberly Jones

	Comment by: Susan Eldon
	Submitted 5 March 2012 \| Permalink	Posted 7 March 2012
	Yes, we need all the help we can get to find out what causes this disease. If the data are reliable, I say we use them. View all comments by Susan Eldon

Submit a Comment on this Site Poll

Cast your vote and/or make a comment on this poll.

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name
*Last Name
Country or Territory:
*Login Email Address
*Password	Minimum of 8 characters
*Confirm Password
Stay signed in?

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:

*Enter the verification code you see in the picture below:

This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:	Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.






			Antibodies Cell Lines Collaborators Papers Research Participants